Buchumschlag

NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia

Relapse of T-cell acute lymphoblastic leukemia (T-ALL) has a dismal prognosis, with only 20% of afflicted children surviving. Children with relapsed T-ALL are commonly treated within high-risk arms of second-line treatment protocols that include mandatory hematopoietic stem cell transplantation (HSC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hof, Jana (VerfasserIn) , Kox, Corinne (VerfasserIn) , Bandapalli, Obul Reddy (VerfasserIn) , Kunz, Joachim (VerfasserIn) , Muckenthaler, Martina (VerfasserIn) , Kulozik, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: July 2017
In: Haematologica
Year: 2017, Jahrgang: 102, Heft: 7, Pages: e249-e252
ISSN:1592-8721
DOI:10.3324/haematol.2016.157792
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2016.157792
Verlag, Volltext: http://www.haematologica.org/content/102/7/e249
Volltext
Verfasserangaben:Jana Hof, Corinne Kox, Stefanie Groeneveld-Krentz, Obul R. Bandapalli, Leonid Karawajew, Katharina Schedel, Joachim B. Kunz, Cornelia Eckert, Wolf-Dieter Ludwig, Richard Ratei, Peter Rhein, Günter Henze, Martina U. Muckenthaler, Andreas E. Kulozik, Arend von Stackelberg, Renate Kirschner-Schwabe
Beschreibung
Zusammenfassung:Relapse of T-cell acute lymphoblastic leukemia (T-ALL) has a dismal prognosis, with only 20% of afflicted children surviving. Children with relapsed T-ALL are commonly treated within high-risk arms of second-line treatment protocols that include mandatory hematopoietic stem cell transplantation (HSCT) if a second complete remission can be induced.
Beschreibung:Gesehen am 17.05.2018
Beschreibung:Online Resource
ISSN:1592-8721
DOI:10.3324/haematol.2016.157792

Ähnliche Einträge